CA3143136C - Derives de pyrido[2,3-d]pyrimidine comme inhibiteurs de capside pour traiter le virus de l'immunodeficience humaine - Google Patents

Derives de pyrido[2,3-d]pyrimidine comme inhibiteurs de capside pour traiter le virus de l'immunodeficience humaine

Info

Publication number
CA3143136C
CA3143136C CA3143136A CA3143136A CA3143136C CA 3143136 C CA3143136 C CA 3143136C CA 3143136 A CA3143136 A CA 3143136A CA 3143136 A CA3143136 A CA 3143136A CA 3143136 C CA3143136 C CA 3143136C
Authority
CA
Canada
Prior art keywords
mmol
compound
stirred
methyl
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3143136A
Other languages
English (en)
Other versions
CA3143136A1 (fr
Inventor
Eric P Gillis
Christiana Iwuagwu
Original Assignee
ViiV Healthcare UK No 5 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ViiV Healthcare UK No 5 Ltd filed Critical ViiV Healthcare UK No 5 Ltd
Priority claimed from PCT/IB2020/055653 external-priority patent/WO2020254985A1/fr
Publication of CA3143136A1 publication Critical patent/CA3143136A1/fr
Application granted granted Critical
Publication of CA3143136C publication Critical patent/CA3143136C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit le composé et les sels pharmaceutiquement acceptables de celui-ci, et les compositions et procédés de traitement d’une infection par le virus de l’immunodéficience humaine (VIH).
CA3143136A 2019-06-19 2020-06-17 Derives de pyrido[2,3-d]pyrimidine comme inhibiteurs de capside pour traiter le virus de l'immunodeficience humaine Active CA3143136C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962863406P 2019-06-19 2019-06-19
US62/863,406 2019-06-19
PCT/IB2020/055653 WO2020254985A1 (fr) 2019-06-19 2020-06-17 Dérivés de pyrido [2,3-d] pyrimidine en tant qu'inhibiteurs de la réplication du virus de l'immunodéficience humaine

Publications (2)

Publication Number Publication Date
CA3143136A1 CA3143136A1 (fr) 2020-12-24
CA3143136C true CA3143136C (fr) 2026-04-07

Family

ID=

Similar Documents

Publication Publication Date Title
AU2020295793B2 (en) Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
EP3917930B1 (fr) Inhibiteurs de la réplication du virus de l'immunodéficience humaine
AU2021256166B2 (en) Inhibitors of human immunodeficiency virus replication
US20230106880A1 (en) Inhibitors of human immunodeficiency virus replication
CA3170536A1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
CA3143136C (fr) Derives de pyrido[2,3-d]pyrimidine comme inhibiteurs de capside pour traiter le virus de l'immunodeficience humaine
RU2804033C2 (ru) Ингибиторы репликации вируса иммунодефицита человека
HK40066649B (en) Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
HK40066649A (en) Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
EA044806B1 (ru) Ингибиторы репликации вируса иммунодефицита человека
CA3173866A1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine